anti-allergy therapy (GSTEP/Milex Biotech)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameanti-allergy therapy (GSTEP/Milex Biotech)
Drug Alias Nameanti-allergy therapy (Gyeonggi Institute of Science & Technology Promotion/Milex/Theragen ETEX)
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionImmunoglobulin E inhibitorsHistamine receptor antagonists
TargetsImmunoglobulin EHistamine receptor
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A